Abrilada and Urinary tract infection - a phase IV clinical study of FDA data

Summary:

Urinary tract infection is reported as a side effect among people who take Abrilada (adalimumab-afzb), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Methotrexate, and have Crohn's disease.

The phase IV clinical study analyzes which people have Urinary tract infection when taking Abrilada. It is created by eHealthMe based on reports of 2,116 people who have side effects when taking Abrilada from the FDA, and is updated regularly.

What is Abrilada?

Abrilada has active ingredients of adalimumab-afzb. eHealthMe is studying from 2,116 Abrilada users. Check the latest studies of Abrilada.

What is Urinary tract infection?

Urinary tract infection is found to be associated with 3,014 drugs and 3,956 conditions by eHealthMe. Check the latest studies of Urinary tract infection.

On Jul, 13, 2026

2,116 people reported to have side effects when taking Abrilada.
Among them, 27 people (1.28%) have Urinary tract infection.

Could Abrilada cause Urinary tract infection?

Among these 27 people:

How long have people been on Abrilada when they have Urinary tract infection? *

What is the gender of people who have Urinary tract infection when taking Abrilada? *

female: 88.89 %
male: 11.11 %

What is the age of people who have Urinary tract infection when taking Abrilada? *

What are other drugs people take besides Abrilada? *

What are other side effects people have besides Urinary tract infection? *

Fatigue (feeling of tiredness): 7 people, 25.93%
Drug Ineffective: 7 people, 25.93%
Pain: 7 people, 25.93%
Nausea (feeling of having an urge to vomit): 6 people, 22.22%
Headache (pain in head): 6 people, 22.22%
Fever: 5 people, 18.52%
Malaise (a feeling of general discomfort or uneasiness): 4 people, 14.81%
Rashes (redness): 4 people, 14.81%
Back Pain: 4 people, 14.81%
Abdominal Pain: 4 people, 14.81%

What are the existing conditions these people have? *

Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 13 people, 48.15%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 18.52%
Ankylosing Spondylitis (type of arthritis affecting the spine): 3 people, 11.11%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 7.41%
Hidradenitis (chronic disease of a type of sweat gland): 2 people, 7.41%
Dyslipidaemia (abnormal amount of lipids): 2 people, 7.41%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 3.70%
Diabetes: 1 person, 3.70%
Cardiac Sarcoidosis (an immune disorder): 1 person, 3.70%

* Approximation only. Some reports may have incomplete information.

Do you take Abrilada and have Urinary tract infection?

- Check whether Urinary tract infection is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Abrilada:

Abrilada (2,116 reports)

Browse all side effects of Abrilada:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Urinary tract infection:

Urinary tract infection (3,014 drugs)

Browse all the conditions that are associated with Urinary tract infection:

Urinary tract infection (3,956 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on adalimumab-afzb (the active ingredients of Abrilada) and Abrilada (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.